BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 34832985)

  • 1. Design and Development of Autotaxin Inhibitors.
    Jia Y; Li Y; Xu XD; Tian Y; Shang H
    Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid produced by autotaxin acts as an allosteric modulator of its catalytic efficiency.
    Salgado-Polo F; Fish A; Matsoukas MT; Heidebrecht T; Keune WJ; Perrakis A
    J Biol Chem; 2018 Sep; 293(37):14312-14327. PubMed ID: 30026231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autotaxin in Pathophysiology and Pulmonary Fibrosis.
    Ninou I; Magkrioti C; Aidinis V
    Front Med (Lausanne); 2018; 5():180. PubMed ID: 29951481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autotaxin facilitates selective LPA receptor signaling.
    Salgado-Polo F; Borza R; Matsoukas MT; Marsais F; Jagerschmidt C; Waeckel L; Moolenaar WH; Ford P; Heckmann B; Perrakis A
    Cell Chem Biol; 2023 Jan; 30(1):69-84.e14. PubMed ID: 36640760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophospholipase D and its role in LPA production.
    Xie Y; Meier KE
    Cell Signal; 2004 Sep; 16(9):975-81. PubMed ID: 15212758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autotaxin: structure-function and signaling.
    Perrakis A; Moolenaar WH
    J Lipid Res; 2014 Jun; 55(6):1010-8. PubMed ID: 24548887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC).
    Sun Y; Zhang W; Evans JF; Floreani A; Zou Z; Nishio Y; Qi R; Leung PS; Bowlus CL; Gershwin ME
    Autoimmun Rev; 2016 Aug; 15(8):795-800. PubMed ID: 27019050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autotaxin in Breast Cancer: Role, Epigenetic Regulation and Clinical Implications.
    Drosouni A; Panagopoulou M; Aidinis V; Chatzaki E
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Function and biological activities of the autotaxin-LPA axis].
    Li ZW; Zhao YR; Zhao C; Fu R; Li ZY
    Sheng Li Xue Bao; 2011 Dec; 63(6):601-10. PubMed ID: 22193457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.
    Black KE; Berdyshev E; Bain G; Castelino FV; Shea BS; Probst CK; Fontaine BA; Bronova I; Goulet L; Lagares D; Ahluwalia N; Knipe RS; Natarajan V; Tager AM
    FASEB J; 2016 Jun; 30(6):2435-50. PubMed ID: 27006447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the autotaxin/LPA axis in cancer development and metastasis.
    Leblanc R; Peyruchaud O
    Exp Cell Res; 2015 May; 333(2):183-189. PubMed ID: 25460336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of non-lipid autotaxin inhibitors.
    Hoeglund AB; Howard AL; Wanjala IW; Pham TC; Parrill AL; Baker DL
    Bioorg Med Chem; 2010 Jan; 18(2):769-76. PubMed ID: 20005724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical introduction of lysophosphatidic acid and autotaxin assays].
    Yatomi Y
    Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation and biological activities of the autotaxin-LPA axis.
    van Meeteren LA; Moolenaar WH
    Prog Lipid Res; 2007 Mar; 46(2):145-60. PubMed ID: 17459484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 3D view of autotaxin.
    Nishimasu H; Ishitani R; Aoki J; Nureki O
    Trends Pharmacol Sci; 2012 Mar; 33(3):138-45. PubMed ID: 22277299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The atherogenic actions of LPC on vascular smooth muscle cells and its LPA receptor mediated mechanism.
    Bao L; Qi J; Wang YW; Xi Q; Tserennadmid T; Zhao PF; Qi J; Damirin A
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1911-1918. PubMed ID: 30064908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an activity-based probe for autotaxin.
    Cavalli S; Houben AJ; Albers HM; van Tilburg EW; de Ru A; Aoki J; van Veelen P; Moolenaar WH; Ovaa H
    Chembiochem; 2010 Nov; 11(16):2311-7. PubMed ID: 20941725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
    Umezu-Goto M; Kishi Y; Taira A; Hama K; Dohmae N; Takio K; Yamori T; Mills GB; Inoue K; Aoki J; Arai H
    J Cell Biol; 2002 Jul; 158(2):227-33. PubMed ID: 12119361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Autotaxin and LPA Signaling in Embryonic Development, Pathophysiology and Cancer.
    Magkrioti C; Kaffe E; Aidinis V
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function relationships of autotaxin, a secreted lysophospholipase D.
    Hausmann J; Perrakis A; Moolenaar WH
    Adv Biol Regul; 2013 Jan; 53(1):112-7. PubMed ID: 23069371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.